(Reuters) - Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.
J&J had sought more than $7 billion in damages after it lost a bidding war to Boston Scientific following an initial deal to buy Guidant for $21.5 billion in 2005. J&J accused Guidant of breaking that deal.
21:52 Netflix nears 94 million subscribers 10 years after streaming launch15
19:08 U.S. indicts three Takata executives, fines company $1 billion in faulty air bag scandal16
23:37 Here’s Why Netflix’s Share Price Just Hit a New All-Time High2
22:33 Allergan to pay $15 million over failing to disclose merger talks18